OTC DEAL TRENDS 2018
31 December 2018 - Deborah Wilkes
The OTCToolbox annual review of mergers and acquisitions activity is essential reading for anyone with an interest in business development in the OTC/consumer healthcare industry.
OTC Deal Trends 2018 provides a comprehensive guide to deals and trends in the global industry.
Mega deals transformed the global industry in 2018 as several pharmaceutical companies divested consumer healthcare/OTC businesses.
Other significant trends included big deals involving vitamins, minerals and supplements (VMS) assets; private-equity firms buying and selling assets; and interest in digital technology and e-commerce assets. There were also many companies buying and building.
However, some acquirers are struggling in the wake of older mega deals.
This authoritative Briefing provides in-depth analysis and insights into past, present and future mergers and acquisitions activity. Download today and read about:
- 10 key OTC deal trends
- Purchase prices for OTC deals
- Big deals in the vitamins, minerals and supplements (VMS) category
- How private-equity companies view the industry
- Creation of pure consumer healthcare companies
- Companies acquiring digital technology
- Companies acquiring e-commerce assets
- Companies investing in microbiome research
- Smaller companies buying and building
- Six company profiles of acquirers and sellers – GSK, P&G, Taisho, J&J, Prestige and Bayer
- What might happen next
Six company profiles:
- GlaxoSmithKline and Pfizer to create global leader
- P&G replaces PGT with Merck Consumer Health
- Taisho extends geographic reach with UPSA
- Prestige to focus on consumer healthcare
- Johnson & Johnson divests Nizoral to three buyers
- Bayer seeks to move on from Merck
The Briefing, which has 129 pages, is written by OTC industry expert Deborah Wilkes, who is the Editor & Publisher of OTCToolbox. It is based on data from the OTCToolbox Transactions Database, which contains details of significant deals in the global consumer healthcare/OTC industry.
It is available to purchase and download immediately from the OTCToolbox website as a PDF. Make sure your team is well informed through a Multiple User Licence or a Global Licence for the Briefing. The Briefing is available free to people who have a current paid-for Annual Subscription to the OTCToolbox website.